tirzepatide pregnancy risks GLP-1s (Weight loss injections) AND πGLP-1 agonists include medications such as and semaglutide which may be better known by their different brand names (such as Wegovy and Mounjaro). They are Tirzepatide Use During Pregnancy
Description
Doubling the receptor load makes them potentially unmanageable

Expected Results: Average weight loss: 15-20% in first 6-12 months

You have unmanaged cardiovascular conditions The glucagon receptor affects heart rate and blood pressure differently than GLP-1 alone

No and any source claiming to sell it should be treated with caution
Hitting three pathways at once is the logic behind why researchers expected and observed larger results

doi: 10.1210/clinem/dgaf336 19
